In this study, we treated various human esophageal epithelial cells including immortalized- or transformed-esophageal epithelial cells and human ESCC cells with EGFR inhibitors and identified factors that could explain the inhibitory effects of EGFR signaling on these cells. This evidence concerns the gene EGFR and esophageal squamous cell carcinoma.